SCIENTURE HOLDINGS, INC. Proceeds from Debt, Net of Issuance Costs
SCIENTURE HOLDINGS, INC. (SCNX) reported Proceeds from Debt, Net of Issuance Costs of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2018-03-02
- SCIENTURE HOLDINGS, INC. proceeds from debt, net of issuance costs for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- SCIENTURE HOLDINGS, INC. proceeds from debt, net of issuance costs for fiscal 2016 was $209.16K.
| Period end | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-02 |
| 2016-12-31 | $209.16K 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |